Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
for Familial Partial Lipodystrophy
7 locations incl. Birmingham
Sponsor: Chiesi Farmaceutici S.p.A.
Sex: All·Age: 13+
Code: NCT06679270·Phase 3·Recruiting·Listed Nov 2024